Apogee Therapeutics, Inc. (APGE)
NASDAQ: APGE · IEX Real-Time Price · USD
38.21
-0.37 (-0.96%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Apogee Therapeutics Market Cap
Apogee Therapeutics has a market cap or net worth of $2.23 billion as of July 2, 2024.
Market Cap
2.23B
Enterprise Value
1.42B
1-Year Change
n/a
Ranking
Category
Stock Price
$38.21
Market Cap Chart
Since the IPO on July 14, 2023, Apogee Therapeutics's market cap has increased from $808.89M to $2.23B, an increase of 176.13%. That is a compound annual growth rate of 185.83%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 1, 2024 | 2.26B | 59.29% |
Dec 29, 2023 | 1.42B | 75.03% |
View and export this data all the way back to 2023.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Celldex Therapeutics | 2.44B |
RxSight | 2.35B |
PTC Therapeutics | 2.35B |
STAAR Surgical Company | 2.34B |
10x Genomics | 2.33B |
Integra LifeSciences Holdings | 2.30B |
Iovance Biotherapeutics | 2.24B |
Structure Therapeutics | 2.24B |